PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's financial stability and solvency. Value investors pay close attention to leverage and liquidity risk, ensuring the company has enough cushion to withstand downturns without impairing shareholder value.
0.01
D/E of 0.01 while RVPH has all-equity financing. Bruce Berkowitz would demand higher returns to justify our leverage.
12.88
Similar net debt to RVPH's 13.52. Guy Spier would examine if industry leverage norms make sense for both companies.
No Data
No Data available this quarter, please select a different quarter.
19.87
Current ratio 50-75% of RVPH's 34.81. Bill Ackman would demand clear path to liquidity improvement.
No Data
No Data available this quarter, please select a different quarter.